about
Liver transplantation for cholangiocarcinoma: Current status and new insightsManagement of "very early" hepatocellular carcinoma on cirrhotic patientsInfluenza A H1N1/2009 infection in pediatric solid organ transplant recipients.Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients.Isolated bilateral Tapia's syndrome after liver transplantation: A case report and review of the literature.Multiple indications for everolimus after liver transplantation in current clinical practice.Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centreAnalysis of adult 20-year survivors after liver transplantationPrognostic factors and time-related changes influence results of colorectal liver metastases surgical treatment: a single-center analysis.Visceral leishmaniasis among liver transplant recipients: an overview.Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature.Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation.Successful long-term outcome of pediatric liver-kidney transplantation: a single-center study.Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.Right-sided diaphragmatic rupture after blunt trauma. An unusual entity.Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1.Outcome of early vs. deferred antiviral treatment for recurrent hepatitis C in liver transplant recipients.Twelve-week posttreatment follow-up to predict sustained virologic response for recurrent hepatitis C infection in liver recipients.Long-term outcome of hepatitis C virus infections acquired after pediatric liver transplantation.Indications and management of everolimus after liver transplantation.Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.Liver transplantation in Catalonia from 1984 to 1997.Indocyanine green plasma disappearance rate: a new tool for the classification of paediatric patients with acute liver failure.[Therapeutic management of juxtapapillary duodenal diverticulum].Impact of valganciclovir on Epstein-Barr Virus polymerase chain reaction in pediatric liver transplantation: preliminary report.Changes in renal function in long-term survivors of liver transplantation: a comparison between cyclosporine microemulsion and tacrolimus therapy.One thousand liver transplants: the hospital clinic experience.Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis.Outcome of hepatitis C virus-associated membranoproliferative glomerulonephritis after liver transplantation.Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series.Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin with rapamycin plus tacrolimus in liver transplant patient.Steroids and living liver donation increase tacrolimus blood levels in living donor liver transplantation.Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.Conversion from twice-daily to once-daily tacrolimus formulation in pediatric liver transplant recipients - a long-term prospective study.Successful multiple organ donation after donor brain death due to Actinomyces israelii meningitis.Acute pancreatitis during pregnancy, 7-year experience of a tertiary referral center.Acute Antibody-Mediated Rejection as Cause of Late Liver Allograft Failure: A Case Report.Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study.Outcome of patients following hepatic resection for metastatic cutaneous and ocular melanoma.Impact of prior portosystemic shunt procedures on outcome of liver transplantation.
P50
Q26783361-2E3C3BB7-9A16-413A-BDE4-2C811710292DQ26864406-48190D2E-2400-4A63-A440-C55670621028Q30421504-E7B095D0-96B9-4EA4-99E6-F2D642C008CEQ30430823-5E37B48D-AE32-4321-B995-1F8A8668BEAEQ31154492-043E13BB-7797-46AC-ABA3-5682291D45EAQ33891730-C28C9B33-1F8F-4105-95D5-A91613A30DC5Q34959580-F8627DCF-9189-463C-8D00-5756126D73D8Q35757871-15C4E7DD-52C3-42B5-AE25-6DABBE265E71Q37214575-CED7000D-6FF6-42F4-8E1F-8B1C40434AF0Q37331906-0AF23AA3-74B8-4A87-BE57-F9BB430EFE39Q37886889-CE5ACA42-641D-429C-A617-F043F7021697Q37973516-9029EA92-6496-4518-B7D9-1032A889E29DQ38607546-919E382D-EDDD-49B1-B7B2-192EBB901951Q38847936-300365E5-6B57-4AC4-853C-724365AE6800Q41826721-3302EE85-1D5F-4680-A68F-C824EABAF8B0Q42232115-678F34B7-815F-4CA5-BB04-29EB0B6437F3Q42236220-FF7B57C2-5687-4495-B031-EB85EBBDD759Q42977026-FED4AAB1-F910-4C65-A9B5-973719FE97A8Q43040672-AD6BDDF4-B830-4061-AF11-A063201EBDC7Q43284025-EEA6CD6F-123D-4AFF-87AA-D60D4844204EQ43620676-D4A028AF-7816-4487-B8CA-EAB5E08063C6Q43860817-ECEEF262-3267-4184-B19A-AD9A23E839FEQ43945247-5FD4CDD7-0A26-413E-BFE6-E4B74FD65F7AQ43963333-C7B24635-7BFC-42F2-860A-8AC76C563B21Q44034044-DBD5A23E-48ED-45D6-BCFA-8145C11EA80AQ44101345-AA717891-80B2-42A3-BF38-7856C5D48783Q44604869-3FE585DE-20F1-4F0D-9B10-A8F43B5ED097Q44713104-9B6BBD52-E9A4-468E-8F0D-C667191DA444Q44737762-02E0749C-3EDE-48B0-9F71-ACD46B940C0FQ45199689-AA2917A3-9313-471B-8EB3-F2F18D67E127Q46045883-B8ACC332-4B09-4EF0-B814-E23116A0CA6BQ46873968-D0253EA6-2C1F-44CC-A906-B6FCA2A69076Q47700671-BD57D00D-9E2B-429E-928B-805937EA2448Q48191085-59A0D3A6-4803-45F1-ABF6-A52C167714A2Q48248917-DE379A55-862D-4C48-AD05-F3404DD6B5E8Q50184073-DA192EDA-D9F5-47E0-82E0-104AE4C64835Q50433623-C34DE5F3-CD2F-45C8-A7D8-7CD9E810FEF9Q50480697-04994A20-6182-4612-B363-6A943A783A02Q50555699-42C1FB06-667B-4FA8-AFEF-79397E53B6C0Q50764610-D885356F-F014-4C6D-BAA8-B2F5A69280ED
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ramón Charco
@ast
Ramón Charco
@en
Ramón Charco
@es
Ramón Charco
@nl
Ramón Charco
@sl
type
label
Ramón Charco
@ast
Ramón Charco
@en
Ramón Charco
@es
Ramón Charco
@nl
Ramón Charco
@sl
prefLabel
Ramón Charco
@ast
Ramón Charco
@en
Ramón Charco
@es
Ramón Charco
@nl
Ramón Charco
@sl
P106
P21
P31
P496
0000-0001-9709-6288